Literature DB >> 15863612

Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.

Igor Splawski1, Katherine W Timothy, Niels Decher, Pradeep Kumar, Frank B Sachse, Alan H Beggs, Michael C Sanguinetti, Mark T Keating.   

Abstract

Timothy syndrome (TS) is a multisystem disorder that causes syncope and sudden death from cardiac arrhythmias. Prominent features include congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities, and autism. All TS individuals have syndactyly (webbing of fingers and toes). We discovered that TS resulted from a recurrent, de novo cardiac L-type calcium channel (CaV1.2) mutation, G406R. G406 is located in alternatively spliced exon 8A, encoding transmembrane segment S6 of domain I. Here, we describe two individuals with a severe variant of TS (TS2). Neither child had syndactyly. Both individuals had extreme prolongation of the QT interval on electrocardiogram, with a QT interval corrected for heart rate ranging from 620 to 730 ms, causing multiple arrhythmias and sudden death. One individual had severe mental retardation and nemaline rod skeletal myopathy. We identified de novo missense mutations in exon 8 of CaV1.2 in both individuals. One was an analogous mutation to that found in exon 8A in classic TS, G406R. The other mutation was G402S. Exon 8 encodes the same region as exon 8A, and the two are mutually exclusive. The spliced form of CaV1.2 containing exon 8 is highly expressed in heart and brain, accounting for approximately 80% of CaV1.2 mRNAs. G406R and G402S cause reduced channel inactivation, resulting in maintained depolarizing L-type calcium currents. Computer modeling showed prolongation of cardiomyocyte action potentials and delayed afterdepolarizations, factors that increase risk of arrhythmia. These data indicate that gain-of-function mutations of CaV1.2 exons 8 and 8A cause distinct forms of TS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863612      PMCID: PMC1149428          DOI: 10.1073/pnas.0502506102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  The open pore conformation of potassium channels.

Authors:  Youxing Jiang; Alice Lee; Jiayun Chen; Martine Cadene; Brian T Chait; Roderick MacKinnon
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

2.  Electrophysiological recording from Xenopus oocytes.

Authors:  W Stühmer
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

3.  Expression of ion channels by injection of mRNA into Xenopus oocytes.

Authors:  A L Goldin
Journal:  Methods Cell Biol       Date:  1991       Impact factor: 1.441

4.  Molecular basis of the long-QT syndrome associated with deafness.

Authors:  I Splawski; K W Timothy; G M Vincent; D L Atkinson; M T Keating
Journal:  N Engl J Med       Date:  1997-05-29       Impact factor: 91.245

5.  Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.

Authors:  M M White; M Aylwin
Journal:  Mol Pharmacol       Date:  1990-05       Impact factor: 4.436

6.  Long QT syndrome associated with syndactyly identified in females.

Authors:  M L Marks; D L Trippel; M T Keating
Journal:  Am J Cardiol       Date:  1995-10-01       Impact factor: 2.778

7.  A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.

Authors:  M C Sanguinetti; C Jiang; M E Curran; M T Keating
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

8.  A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes.

Authors:  C H Luo; Y Rudy
Journal:  Circ Res       Date:  1994-06       Impact factor: 17.367

Review 9.  A new form of long QT syndrome associated with syndactyly.

Authors:  M L Marks; S L Whisler; C Clericuzio; M Keating
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

10.  [The heart-hand syndrome. A new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet].

Authors:  H Reichenbach; E M Meister; H Theile
Journal:  Kinderarztl Prax       Date:  1992-04
View more
  246 in total

1.  Expanding clinical phenotype in CACNA1C related disorders: From neonatal onset severe epileptic encephalopathy to late-onset epilepsy.

Authors:  Xiuhua Bozarth; Jennifer N Dines; Qian Cong; Ghayda M Mirzaa; Kimberly Foss; J Lawrence Merritt; Jenny Thies; Heather C Mefford; Edward Novotny
Journal:  Am J Med Genet A       Date:  2018-12-04       Impact factor: 2.802

2.  DUSP4 regulates neuronal differentiation and calcium homeostasis by modulating ERK1/2 phosphorylation.

Authors:  Sun Young Kim; Yong-Mahn Han; Mihee Oh; Won-Kon Kim; Kyoung-Jin Oh; Sang Chul Lee; Kwang-Hee Bae; Baek-Soo Han
Journal:  Stem Cells Dev       Date:  2014-12-23       Impact factor: 3.272

Review 3.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

4.  Genome-wide association analysis identifies multiple loci related to resting heart rate.

Authors:  Mark Eijgelsheim; Christopher Newton-Cheh; Nona Sotoodehnia; Paul I W de Bakker; Martina Müller; Alanna C Morrison; Albert V Smith; Aaron Isaacs; Serena Sanna; Marcus Dörr; Pau Navarro; Christian Fuchsberger; Ilja M Nolte; Eco J C de Geus; Karol Estrada; Shih-Jen Hwang; Joshua C Bis; Ina-Maria Rückert; Alvaro Alonso; Lenore J Launer; Jouke Jan Hottenga; Fernando Rivadeneira; Peter A Noseworthy; Kenneth M Rice; Siegfried Perz; Dan E Arking; Tim D Spector; Jan A Kors; Yurii S Aulchenko; Kirill V Tarasov; Georg Homuth; Sarah H Wild; Fabio Marroni; Christian Gieger; Carmilla M Licht; Ronald J Prineas; Albert Hofman; Jerome I Rotter; Andrew A Hicks; Florian Ernst; Samer S Najjar; Alan F Wright; Annette Peters; Ervin R Fox; Ben A Oostra; Heyo K Kroemer; David Couper; Henry Völzke; Harry Campbell; Thomas Meitinger; Manuela Uda; Jacqueline C M Witteman; Bruce M Psaty; H-Erich Wichmann; Tamara B Harris; Stefan Kääb; David S Siscovick; Yalda Jamshidi; André G Uitterlinden; Aaron R Folsom; Martin G Larson; James F Wilson; Brenda W Penninx; Harold Snieder; Peter P Pramstaller; Cornelia M van Duijn; Edward G Lakatta; Stephan B Felix; Vilmundur Gudnason; Arne Pfeufer; Susan R Heckbert; Bruno H Ch Stricker; Eric Boerwinkle; Christopher J O'Donnell
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

Review 5.  HERG1 channelopathies.

Authors:  Michael C Sanguinetti
Journal:  Pflugers Arch       Date:  2009-11-22       Impact factor: 3.657

Review 6.  Cardiac ion channels.

Authors:  Birgit T Priest; Jeff S McDermott
Journal:  Channels (Austin)       Date:  2015-08-20       Impact factor: 2.581

7.  The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation.

Authors:  Viktor Yarotskyy; Guofeng Gao; Blaise Z Peterson; Keith S Elmslie
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

8.  Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8).

Authors:  Benjamin M L Drum; Rose E Dixon; Can Yuan; Edward P Cheng; Luis F Santana
Journal:  J Mol Cell Cardiol       Date:  2013-11-09       Impact factor: 5.000

9.  Phosphorylation sites required for regulation of cardiac calcium channels in the fight-or-flight response.

Authors:  Ying Fu; Ruth E Westenbroek; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

10.  Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.

Authors:  Worawan B Limpitikul; Ivy E Dick; Rosy Joshi-Mukherjee; Michael T Overgaard; Alfred L George; David T Yue
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.